The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Life Science Market Reports

SynopsisThe global Drug-Eluting Bioabsorbable Stents market size is expected to reach US$ 1217.4 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029. The market is mainly driven by the significant applications of Drug-Eluting Bioabsorbable Stents in various e.....

No Of Pages : 103
Publication Date: Mar, 2025
Single User Price : US$ 3,350.00

SynopsisBrachytherapy is a form of radiotherapy where a sealed radiation source is placed inside or next to the area requiring treatment. Brachytherapy is commonly used as an effective treatment for cervical, prostate, breast, and skin cancer and can also be used to t.....

No Of Pages : 89
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisImmune globulin (Ig) short-term protection against hepatitis A and measles The global Immune Globulin Intravenous market size is expected to reach US$ 21770 million by 2029, growing at a CAGR of 7.1% from 2023 to 2029. The market is mainly driven by the .....

No Of Pages : 105
Publication Date: Mar, 2025
Single User Price : US$ 3,350.00

SynopsisThe global Benchtop Bioreactors market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Benchtop Bioreactors is estimated to increase.....

No Of Pages : 96
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisIschemic hepatitis is also known as shock liver is a condition affecting 0.18%–0.50% of inpatient admissions per year. Usually, the affected patient has no abdominal pain symptoms and the diagnosis is based on biochemical blood analysis. In ischemic hepatitis .....

No Of Pages : 76
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisAn angiotensin-converting-enzyme inhibitor (ACE inhibitor) is a pharmaceutical drug used primarily for the treatment of hypertension (elevated blood pressure) and congestive heart failure. The global Angiotensin Converting Enzyme (ACE) Inhibitors market .....

No Of Pages : 87
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisFenofibrate, marketed as Tricor and under several other brand names, is a drug of the fibrate class. It is mainly used to reduce cholesterol levels in people at risk of cardiovascular disease. Like other fibrates, it reduces both low-density lipoprotein (LDL) .....

No Of Pages : 98
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00